These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension? Arnett DK; Claas SA; Lynch AI Curr Opin Cardiol; 2009 Jul; 24(4):333-9. PubMed ID: 19509486 [TBL] [Abstract][Full Text] [Related]
27. Genetic mapping and tailored antihypertensive therapy. Ferrari P; Bianchi G Cardiovasc Drugs Ther; 2000 Aug; 14(4):387-95. PubMed ID: 10999645 [TBL] [Abstract][Full Text] [Related]
28. Genetics of human hypertension, the role of angiotensinogen. should it be one of the drug target genes? Kolovou GD; Mavrogeni S Angiology; 2014 Apr; 65(4):269-71. PubMed ID: 23719091 [No Abstract] [Full Text] [Related]
29. Gene-environment interactions of selected pharmacogenes in arterial hypertension. Bochud M; Guessous I Expert Rev Clin Pharmacol; 2012 Nov; 5(6):677-86. PubMed ID: 23234325 [TBL] [Abstract][Full Text] [Related]
30. Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses. Turner ST; Boerwinkle E Pharmacogenomics; 2003 Jan; 4(1):53-65. PubMed ID: 12517286 [TBL] [Abstract][Full Text] [Related]
31. Issues in drug metabolism of major antihypertensive drugs: beta-blockers, calcium channel antagonists and angiotensin receptor blockers. Höcht C; Bertera FM; Mayer MA; Taira CA Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):199-211. PubMed ID: 20095790 [TBL] [Abstract][Full Text] [Related]
32. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study). Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745 [TBL] [Abstract][Full Text] [Related]
35. Hypertension pharmacogenomics: in search of personalized treatment approaches. Cooper-DeHoff RM; Johnson JA Nat Rev Nephrol; 2016 Feb; 12(2):110-22. PubMed ID: 26592190 [TBL] [Abstract][Full Text] [Related]
36. Genome-wide association studies of hypertension: have they been fruitful? Rafiq S; Anand S; Roberts R J Cardiovasc Transl Res; 2010 Jun; 3(3):189-96. PubMed ID: 20560039 [TBL] [Abstract][Full Text] [Related]
37. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses). McDonough CW; Magvanjav O; Sá ACC; El Rouby NM; Dave C; Deitchman AN; Kawaguchi-Suzuki M; Mei W; Shen Y; Singh RSP; Solayman M; Bailey KR; Boerwinkle E; Chapman AB; Gums JG; Webb A; Scherer SE; Sadee W; Turner ST; Cooper-DeHoff RM; Gong Y; Johnson JA Circ Genom Precis Med; 2018 Apr; 11(4):e001854. PubMed ID: 29650764 [TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetic implications for eight common blood pressure-associated single-nucleotide polymorphisms. Hamrefors V; Sjögren M; Almgren P; Wahlstrand B; Kjeldsen S; Hedner T; Melander O J Hypertens; 2012 Jun; 30(6):1151-60. PubMed ID: 22525200 [TBL] [Abstract][Full Text] [Related]